Madam Speaker, over 4,200 Canadians have cystic fibrosis. Unfortunately, one of the most promising treatments for CF is not available in Canada because of the regulatory uncertainty that the current Liberal government has introduced into Canada's patented drug market. Trikafta is a drug that has the potential to treat 90% of CF patients. It is a lifeline that is available in the U.S. and U.K. but not here in Canada.
I recently met with a mother in my riding who suffers from CF. She is terrified because she is at risk of severe COVID-related complications. Her doctor believes she would greatly benefit from Trikafta.
On behalf of my constituents and all Canadians with CF, I am asking the Minister of Health to take to heart the plight of these people, and do what needs to be done to bring Trikafta here to Canada.